KCNMB4

KCNMB4 encodes the β4 regulatory subunit of large-conductance Ca²⁺-activated K⁺ (BK) channels, which co-assembles with the pore-forming α-subunit (KCNMA1) to confer iberiotoxin resistance and slow gating kinetics, thereby modulating neuronal excitability, renal K⁺/Na⁺ handling, aqueous humor outflow, sympathetic tone, and mucociliary clearance (PMID:12388098, PMID:20299355, PMID:32203982, PMID:29562421, PMID:24414257). Activity-dependent downregulation of KCNMB4 after seizures switches BK channels from slow-gating type II (α/β4) to fast-gating type I (α alone), increasing neuronal excitability and seizure susceptibility (PMID:29145442). Surface expression of β4-containing channels is governed by S-acylation controlling ER exit rather than channel kinetics (PMID:25140154), while transcription is positively regulated by PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter and negatively regulated by estrogen-dependent miR-504 (PMID:41513606, PMID:32653540). The β4 subunit also localizes to neuronal mitochondrial inner membranes, where it participates in mitochondrial BK channel function (PMID:18359571).

1. 2002 High

   Demonstrating that KCNMB4 co-assembles with KCNMA1 to form heteromeric BK channels with altered iberiotoxin pharmacology established that β4 is a bona fide modulatory subunit of the BK channel complex.

   Evidence Heterologous expression, patch-clamp electrophysiology, and β1 knockout mouse pharmacology in parotid acinar cells

   PMID:12388098

   Open questions at the time

   • Stoichiometry of α/β4 assembly not determined
   • No structural data on β4–α interface
   • Tissue-specific assembly rules unknown
2. 2003 Medium

   Identifying β4-containing BK channels in hippocampal astrocytes gated by metabotropic glutamate receptor signaling via Gi/PLC/CYP450 epoxygenase revealed a glial signaling axis for BK channel regulation.

   Evidence RT-PCR, Northern blot, single-channel patch-clamp with pertussis toxin, PLC inhibitors, and mGluR antagonists in rat astrocytes

   PMID:12629172

   Open questions at the time

   • Direct protein–protein interaction between β4 and signaling intermediates not shown
   • Functional consequence of astrocytic β4-BK activation on neural circuits not tested
3. 2008 Medium

   Localization of β4 to the inner membrane of a subpopulation of neuronal mitochondria extended the functional geography of KCNMB4 beyond the plasma membrane, implicating it in mitochondrial K⁺ homeostasis.

   Evidence Immunoelectron microscopy and immunofluorescence with subunit-specific antibodies in rat brain

   PMID:18359571

   Open questions at the time

   • Functional electrophysiology of mitochondrial β4-BK not performed
   • Mechanism of β4 targeting to mitochondria unknown
   • Role in mitochondrial physiology not directly tested
4. 2010 High

   Kcnmb4 knockout mice revealed that β4-containing BK channels in renal intercalated cells are required for potassium adaptation, controlling fractional K⁺/Na⁺ excretion, urinary flow, and intercalated cell remodeling.

   Evidence Kcnmb4 knockout mouse with metabolic cage studies, immunohistochemistry, and plasma electrolyte measurements

   PMID:20299355

   Open questions at the time

   • Cell-type-specific conditional knockout not performed
   • Downstream signaling linking β4-BK to cell size regulation unknown
5. 2014 Medium

   Two parallel discoveries revealed that β4 surface expression is controlled by S-acylation governing ER exit (not channel kinetics), and that IFN-γ–mediated KCNMB4 downregulation in airway epithelium impairs mucociliary clearance, extending β4's roles to trafficking control and innate defense.

   Evidence Biochemical S-acylation assays with surface expression measurements; air-liquid interface culture of human airway cells with RT-PCR, ASL volume, and ciliary beat frequency

   PMID:24414257 PMID:25140154

   Open questions at the time

   • Identity of the acyltransferase(s) acting on β4 unknown
   • Whether S-acylation is dynamically regulated in vivo not established
   • Relative contribution of β4 vs. LRRC26 loss to the airway phenotype not resolved
6. 2017 High

   Activity-dependent downregulation of KCNMB4 after seizures mechanistically explained how BK channels switch from type II (slow-gating, iberiotoxin-resistant) to type I (fast-gating, iberiotoxin-sensitive), directly increasing neuronal excitability; even β4 haploinsufficiency was sufficient to lower seizure threshold.

   Evidence Pilocarpine seizure model, qRT-PCR, single-channel recording, iberiotoxin pharmacology, and heterozygous β4 knockout mice with seizure threshold testing

   PMID:29145442

   Open questions at the time

   • Transcriptional mechanism driving post-seizure KCNMB4 downregulation not identified
   • Whether β4 restoration rescues seizure susceptibility not tested
7. 2018 Medium

   Knockdown of KCNMB4 in the paraventricular nucleus increased renal sympathetic nerve activity and worsened cardiac function, establishing β4-BK channels as central suppressors of sympathetic outflow in heart failure.

   Evidence rAAV2-shRNA knockdown in rat PVN, renal sympathetic nerve recording, echocardiography in coronary artery ligation CHF model

   PMID:29562421

   Open questions at the time

   • Mechanism of KCNMB4 downregulation in CHF not determined
   • Cell-type identity of β4-expressing PVN neurons not established
8. 2020 High

   Two studies expanded regulatory understanding: β4-containing BK channels were shown to be the dominant BK subtype controlling aqueous humor outflow in the eye, and estrogen-dependent miR-504 was identified as a negative regulator of KCNMB4 expression underlying sex differences in baroreceptor neuron excitability.

   Evidence iPerfusion with martentoxin in mouse eyes, qPCR/immunofluorescence in trabecular meshwork; ovariectomy model with patch-clamp and miR-504 expression correlation in nodose ganglia

   PMID:32203982 PMID:32653540

   Open questions at the time

   • Direct miR-504 binding to KCNMB4 3′UTR not validated by reporter assay
   • In vivo IOP phenotype of β4 knockout not tested
   • Whether miR-504 regulation occurs in tissues beyond nodose ganglia unknown
9. 2026 Medium

   Identification of PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter as a transcriptional activator linked β4 upregulation to paclitaxel resistance in nasopharyngeal carcinoma, revealing an epigenetic axis controlling KCNMB4 expression.

   Evidence ChIP for PRMT5 and H3R2me2s at KCNMB4 promoter, PRMT5 genetic/pharmacological inhibition, in vitro and in vivo drug resistance assays

   PMID:41513606

   Open questions at the time

   • Whether PRMT5 regulation of KCNMB4 operates in non-cancer contexts unknown
   • Downstream mechanism linking β4-BK to chemoresistance not resolved

• Key unresolved questions include the structural basis of α/β4 assembly and how it confers slow gating, the identity of acyltransferases and deacylases controlling β4 S-acylation, the transcriptional mechanism of seizure-induced KCNMB4 downregulation, and the functional role of β4 in mitochondrial BK channels.
• No cryo-EM or crystal structure of α/β4 complex
• No reconstitution of mitochondrial β4-BK channel activity
• Transcription factor(s) mediating activity-dependent KCNMB4 repression unidentified